{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T14:29:10Z","timestamp":1768919350371,"version":"3.49.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.urolonc.2023.06.005","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T15:16:55Z","timestamp":1691421415000},"page":"435.e11-435.e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Conditional survival of stage III non-seminoma testis cancer patients"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8577-2274","authenticated-orcid":false,"given":"Reha-Baris","family":"Incesu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Barletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Tappero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Morra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina Cano","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Scheipner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia Luca","family":"Piccinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ottavio","family":"de Cobelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sascha","family":"Ahyai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix K.H.","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Terrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derya","family":"Tilki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Graefen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2023.06.005_bib0001","doi-asserted-by":"crossref","unstructured":"Ghazarian AA, Kelly SP, Altekruse SF, Rosenberg PS, Mcglynn KA. Future of testicular germ cell tumor incidence in the United States: forecast through 2026. doi:10.1002\/cncr.30597.","DOI":"10.1002\/cncr.30597"},{"issue":"3","key":"10.1016\/j.urolonc.2023.06.005_bib0002","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/ijc.32810","article-title":"Testicular cancer incidence predictions in Europe 2010-2035: a rising burden despite population ageing HHS Public Access","volume":"147","author":"Znaor","year":"2020","journal-title":"Int J Cancer"},{"issue":"14","key":"10.1016\/j.urolonc.2023.06.005_bib0003","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1200\/JCO.20.03296","article-title":"Predicting outcomes in men with metastatic non-seminomatous germ cell tumors (NSGCT): Results from the IGCCCG update consortium","volume":"39","author":"Gillessen","year":"2021","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2023.06.005_bib0004","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.clgc.2019.06.003","article-title":"Contemporary incidence and mortality rates in patients with testicular germ cell tumors","volume":"17","author":"Palumbo","year":"2019","journal-title":"Clin Genitourin Cancer"},{"issue":"2","key":"10.1016\/j.urolonc.2023.06.005_bib0005","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.eururo.2013.09.050","article-title":"Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time","volume":"66","author":"Ploussard","year":"2014","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.urolonc.2023.06.005_bib0006","doi-asserted-by":"crossref","DOI":"10.1111\/bju.12115","article-title":"Conditional survival after nephrectomy for renal cell carcinoma (RCC): changes in future survival probability over time","volume":"111","author":"Bianchi","year":"2013","journal-title":"BJU Int"},{"issue":"12","key":"10.1016\/j.urolonc.2023.06.005_bib0007","first-page":"893","article-title":"How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder","volume":"37","author":"Palumbo","year":"2019","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"7","key":"10.1016\/j.urolonc.2023.06.005_bib0008","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1200\/JCO.2015.64.7909","article-title":"Conditional survival of patients with metastatic testicular germ cell tumors treated with first-line curative therapy","volume":"34","author":"Ko","year":"2016","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.urolonc.2023.06.005_bib0009","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1200\/JCO.2009.25.9697","article-title":"Clinical relevance of conditional survival of cancer patients in Europe: age-specific analyses of 13 cancers","volume":"28","author":"Janssen-Heijnen","year":"2010","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2023.06.005_bib0010","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/annonc\/mdv131","article-title":"Life expectancy of colon, breast, and testicular cancer patients: an analysis of US-SEER population-based data","volume":"26","author":"Capocaccia","year":"2015","journal-title":"Annals Oncol"},{"issue":"7","key":"10.1016\/j.urolonc.2023.06.005_bib0011","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1158\/1078-0432.CCR-14-2154","article-title":"Conditional survival: a useful concept to provide information on how prognosis evolves over time","volume":"21","author":"Hieke","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2023.06.005_bib0012","series-title":"R: A language and environment for statistical computing","year":"2022"},{"key":"10.1016\/j.urolonc.2023.06.005_bib0013","unstructured":"Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2018, National Cancer Institute. https:\/\/seer.cancer.gov\/csr\/1975_2018\/."},{"issue":"12","key":"10.1016\/j.urolonc.2023.06.005_bib0014","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/jnci\/djz106","article-title":"Annual report to the nation on the status of cancer, featuring cancer in men and women age 20\u201349 years","volume":"111","author":"Ward","year":"2019","journal-title":"JNCI: J Nat Cancer Institute"},{"issue":"3","key":"10.1016\/j.urolonc.2023.06.005_bib0015","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.urolonc.2023.06.005_bib0016","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.euo.2018.04.005","article-title":"Practice patterns and impact of postchemotherapy retroperitoneal lymph node dissection on testicular cancer outcomes","volume":"1","author":"Woldu","year":"2018","journal-title":"Eur Urol Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143923002181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143923002181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:28:02Z","timestamp":1761042482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143923002181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1078143923002181"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2023.06.005","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conditional survival of stage III non-seminoma testis cancer patients","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2023.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}